8-K: Vireo Growth Inc. Completes Acquisition of WholesomeCo Cannabis and Arches Technology Platform

Vireo Growth Inc. finalizes the acquisition of WholesomeCo Cannabis and Arches technology platform, aiming to boost profitability and gain a competitive edge.

Summary

• Vireo Growth Inc. has completed its acquisition of WholesomeCo Cannabis and the Arches technology platform on May 12, 2025.
• The total consideration for the acquisition was $69.8 million, paid in the form of 134.2 million subordinate voting shares of Vireo at a reference price of $0.52 per share.
• The purchase price for Wholesome represents a multiple of 4.175x its 2024 Reference EBITDA of $16 million.
• The former Wholesome stockholders have agreed to a voluntary share lock-up for a 33-month period.
• The acquisition is expected to strengthen Vireo's profitability and provide a competitive advantage through the Arches technology platform.
• Vireo issued 120,806,952 subordinate voting shares as the Closing Share Payment.
• 13,423,034 Parent Shares (representing 10% of the aggregate number of Parent Shares issued as part of the Estimated Closing Merger Consideration), which were delivered to Odyssey Trust Company in its capacity as escrow agent.
• Former Wholesome stockholders are entitled to earn-out payments based on the performance of Arches, based on the greater of US$37.5 million or 5x certain revenue percentages of Arches minus $4,000,000, with such revenue percentage amounts measured at the higher of trailing-twelve-month or nine-month annualized amounts as of December 31, 2026, paid out using a share price for the Parent Shares at the higher of US$1.05 or 20-day volume weighted average price (VWAP) ending immediately prior to December 31, 2026, which as of the Closing Date represent approximately 84.72% of the issued and outstanding equity securities of Arches .
• Former stockholders of Wholesome may also receive additional Parent Shares pursuant to earn-out payments based on Wholesomes Adjusted EBITDA growth compared to Wholesomes Closing EBITDA (at a 4x multiple), adjusted for incremental debt and certain other matters, and paid out using a share price for the Parent Shares of the higher of US$1.05 or the 20-day VWAP as of immediately prior to December 31, 2026.
• The Merger Agreement provides for the clawback of up to 50% of the Parent Shares issued as Actual Closing Merger Consideration (excluding the Parent Shares issued as consideration for the Arches Value Amount), if (a) 2026 Adjusted EBITDA is less than 96.5% of the Closing EBITDA (the amount of such shortfall, the EBITDA Deficiency), and (b) retail revenue Market Share or EBITDA Margin for 2026 is less than the corresponding figures for 2024 and (c) the Companys 20-day VWAP as of immediately prior to December 31, 2026 is greater than US$1.05 per share.

Sentiment

Score: 7

Explanation: The document is generally positive, highlighting the completion of a strategic acquisition and expected benefits. However, it also includes cautionary statements about risks and uncertainties, preventing a higher score.

Positives

• The acquisition of WholesomeCo Cannabis provides Vireo with a dominant position in the Utah medical market.
• The Arches technology platform offers sophisticated digital marketing and consumer loyalty capabilities.
• The acquisition is expected to strengthen Vireo's profitability profile.
• The share lock-up agreement with former WholesomeCo stockholders demonstrates their confidence in the combined company's future.
• The performance-based earn-out structure aligns the interests of the sellers with Vireo's long-term success.

Negatives

• The consideration was paid in shares, which could dilute existing shareholders.
• The earn-out payments are contingent on future performance, which may not be achieved.
• The clawback provisions indicate a potential risk if WholesomeCo does not meet certain performance milestones.
• The lock-up agreements restrict the ability of WholesomeCo stockholders to sell their shares for a period of time.

Risks

• The success of the acquisition depends on the integration of WholesomeCo and Arches into Vireo's existing operations.
• Regulatory changes in the cannabis industry could impact the profitability of the combined company.
• The earn-out payments and clawback provisions introduce uncertainty regarding the final purchase price.
• The company's ability to achieve the EBITDA targets required for RSU vesting is not guaranteed.
• The lock-up agreements could create selling pressure when the restrictions are lifted.

Future Outlook

Vireo management expects its other pending merger transactions to close during the second quarter of 2025.

Management Comments

• The acquisitions of Wholesome and Arches are expected to further strengthen the Company's profitability profile and provide a unique opportunity to build competitive advantages in other markets with a proprietary technology and analytics platform.

Industry Context

The acquisition reflects a trend of consolidation in the cannabis industry, with companies seeking to expand their market presence and improve profitability through strategic acquisitions and technology integration.

Comparison to Industry Standards

• Comparable companies in the cannabis industry, such as Curaleaf, Trulieve, and Green Thumb Industries, have also pursued acquisitions to expand their market share and geographic footprint.
• The 4.175x EBITDA multiple paid for WholesomeCo is within the range of recent cannabis industry transactions, but the specific terms and conditions, such as the lock-up agreements and clawback provisions, are unique to this deal.
• The Arches technology platform is intended to provide a competitive advantage similar to the proprietary technology platforms developed by other leading cannabis companies to enhance customer loyalty and optimize marketing efforts.

Stakeholder Impact

• Shareholders will be impacted by the issuance of new shares and the potential for future dilution.
• Employees of WholesomeCo and Arches will be integrated into Vireo's workforce.
• Customers of WholesomeCo will have access to a broader range of products and services.
• The acquisition could impact suppliers and other business partners of WholesomeCo and Arches.

Next Steps

• Integration of WholesomeCo and Arches into Vireo's existing operations.
• Achievement of performance milestones to avoid clawback provisions.
• Potential issuance of earn-out shares based on future performance.
• Closing of other pending merger transactions during the second quarter of 2025.

Key Dates

Keywords

acquisition, merger, cannabis, EBITDA, Vireo Growth, WholesomeCo, Arches, lock-up, shares, RSUs